BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35351996)

  • 1. Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells.
    Yang YS; Jia XZ; Lu QY; Cai SL; Huang XT; Yang SH; Wood C; Wang YH; Zhou JJ; Chen YD; Yang JS; Yang WJ
    Oncogene; 2022 Apr; 41(18):2624-2637. PubMed ID: 35351996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia).
    Wood CR; Wu WT; Yang YS; Yang JS; Xi Y; Yang WJ
    Adv Cancer Res; 2023; 158():199-231. PubMed ID: 36990533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.
    Privette Vinnedge LM; McClaine R; Wagh PK; Wikenheiser-Brokamp KA; Waltz SE; Wells SI
    Oncogene; 2011 Jun; 30(24):2741-52. PubMed ID: 21317931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Complexity of DEK Signaling in Cancer Progression.
    Teng Y; Lang L; Jauregui CE
    Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.
    Ye S; Ding YF; Jia WH; Liu XL; Feng JY; Zhu Q; Cai SL; Yang YS; Lu QY; Huang XT; Yang JS; Jia SN; Ding GP; Wang YH; Zhou JJ; Chen YD; Yang WJ
    Cancer Res; 2019 Sep; 79(18):4729-4743. PubMed ID: 31308046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
    Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
    PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unique DEK oncoprotein in women's health: A potential novel biomarker.
    de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
    Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dek Modulates Global Intron Retention during Muscle Stem Cells Quiescence Exit.
    Yue L; Wan R; Luan S; Zeng W; Cheung TH
    Dev Cell; 2020 Jun; 53(6):661-676.e6. PubMed ID: 32502396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.
    Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI
    Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.
    Chen Z; Huo D; Li L; Liu Z; Li Z; Xu S; Huang Y; Wu W; Zhou C; Liu Y; Kuang M; Wu F; Li H; Qian P; Song G; Wu X; Chen J; Hou Y
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33755722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.
    Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
    Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
    Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
    J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA SOX2OT maintains the stemness of pancreatic cancer cells by regulating DEK via interacting with miR-200a/141.
    Liu CS; Zhou Q; Zhang YD; Fu Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2368-2379. PubMed ID: 32196588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
    Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
    FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
    Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
    Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging-based study demonstrates how the DEK nanoscale distribution differentially correlates with epigenetic marks in a breast cancer model.
    Pierzynska-Mach A; Cainero I; Oneto M; Ferrando-May E; Lanzanò L; Diaspro A
    Sci Rep; 2023 Aug; 13(1):12749. PubMed ID: 37550322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.
    Mor-Vaknin N; Saha A; Legendre M; Carmona-Rivera C; Amin MA; Rabquer BJ; Gonzales-Hernandez MJ; Jorns J; Mohan S; Yalavarthi S; Pai DA; Angevine K; Almburg SJ; Knight JS; Adams BS; Koch AE; Fox DA; Engelke DR; Kaplan MJ; Markovitz DM
    Nat Commun; 2017 Feb; 8():14252. PubMed ID: 28165452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
    Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
    Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.